-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, MHigiPclYNL/x3KuKDd9OZj+GIZWb0TdNd8FDlwRenlrrtHCovhUciOmNp+ecDaR kQaAuDAmlRj9Mqc5NxQcyg== 0001005477-07-010386.txt : 20071219 0001005477-07-010386.hdr.sgml : 20071219 20071219140807 ACCESSION NUMBER: 0001005477-07-010386 CONFORMED SUBMISSION TYPE: 4/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20071213 FILED AS OF DATE: 20071219 DATE AS OF CHANGE: 20071219 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: REPLIGEN CORP CENTRAL INDEX KEY: 0000730272 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 042729386 STATE OF INCORPORATION: DE FISCAL YEAR END: 0331 BUSINESS ADDRESS: STREET 1: 41 SEYON STREET STREET 2: BUILDING 1, SUITE 100 CITY: WALTHAM STATE: MA ZIP: 02453 BUSINESS PHONE: 7814499560 MAIL ADDRESS: STREET 1: 41 SEYON STREET STREET 2: BUILDING 1, SUITE 100 CITY: WALTHAM STATE: MA ZIP: 02453 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: RUSCHE JAMES R CENTRAL INDEX KEY: 0001241031 FILING VALUES: FORM TYPE: 4/A SEC ACT: 1934 Act SEC FILE NUMBER: 000-14656 FILM NUMBER: 071315938 BUSINESS ADDRESS: BUSINESS PHONE: 7812500111 MAIL ADDRESS: STREET 1: C/O REPLIGEN CORP 41 STREET 2: SEYON ST. BUILDING 1, SUITE 100 CITY: WALTHAM STATE: MA ZIP: 02453 4/A 1 edgar123.xml AMENDMENT TO FORM 4 X0202 4/A 2007-12-13 2007-12-14 0 0000730272 REPLIGEN CORP RGEN 0001241031 RUSCHE JAMES R C/O REPLIGEN CORPORATION 41 SEYON STREET, BUILDING 1, SUITE 100 WALTHAM MA 02453 0 1 0 0 Senior Vice President Common Stock 2007-12-13 4 S 0 900 6.17 D 114974 D c 2007-12-13 4 S 0 2357 6.15 D 112617 D Common Stock 2007-12-13 4 S 0 12443 6.14 D 100174 D Common Stock 2007-12-13 4 S 0 2200 6.13 D 97974 D Common Stock 2007-12-13 4 S 0 2100 6.12 D 95874 D Common Stock 1.41 2007-12-13 4 M 0 30000 0 A 2008-04-29 Common stock 30000 0 D 7,500 shares exercisable at 4/29/1999, 4/29/2000, 4/29/2001 and 4/29/2002. Incorrectly reported zero in Part I, Block 5 as the Amount of Securities Beneficially Owned Following Reported Transaction. Incorrectly reported zero in Part I, Block 5 as the Amount of Securities Beneficially Owned Following Reported Transaction. Incorrectly reported zero in Part I, Block 5 as the Amount of Securities Beneficially Owned Following Reported Transaction. Incorrectly reported zero in Part I, Block 5 as the Amount of Securities Beneficially Owned Following Reported Transaction. Incorrectly left Part II blank. This section should have reflected exercise of 30,000 shares at $1.41 on 12/13/2007. 7,500 shares exercisable at 4/29/1999, 4/29/2000, 4/29/2001 and 4/29/2002. Correction of the original amount reported in Table I, Block 5 for the "Amount of Securities Beneficially Owned Following Reported Transactions" for the stock sales. Completion of Table II for the exercise of 30,000 shares at $1.41 per share on 12/31/2007. James R. Rusche 2007-12-19 -----END PRIVACY-ENHANCED MESSAGE-----